High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?

Cancer Epidemiology

Volumn 36, Issue 3, 2012, Pages 263-269

  Atashili, Julius ^a,b,c   Adimora, Adaora A ^c   Ndumbe, Peter M ^a,b   Ikomey, George M ^a,b   Rinas, Allen C ^c   Myers, Evan ^c   Eron, Joseph ^c   Smith, Jennifer S ^c   Miller, William C ^c  

^a UNIVERSITY OF BUEA   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cameroon; Cervical neoplasm; Epidemiology; HIV; Screening

Indexed keywords

ANTIRETROVIRUS AGENT;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CAMEROON; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; CERVICAL SQUAMOUS INTRAEPITHELIAL LESION; COLPOSCOPY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAMEROON; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PREVALENCE; SEVERITY OF ILLNESS INDEX; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84860691734     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.10.003     Document Type: Article

References (21)

1. WHO Preparing for the introduction of HPV vaccines: policy and programme guidance for countries 2006, WHO, Geneva.
2. Palefsky J. HPV infection and HPV-associated neoplasia in immunocompromised women. Int J Gynaecol Obstet 2006, 94(Suppl. 1):S56-S64.
3. De Vuyst H., Lillo F., Broutet N., Smith J.S. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008, 17(6):545-554.
4. Franceschi S., Jaffe H. Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis 2007, 45(4):510-513.
5. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287(16):2114-2119.
6. Rothman K.J., Greenland S., Lash T.L. Modern epidemiology 2008, Lippincott Williams & Wilkins, Philadelphia. third edition.
7. Harrell F.E. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis 2001, Springer, New York.
8. Mbu E.R., Kongnyuy E.J., Mbopi-Keou F., Tonye R.N., Nana P.N., Leke R.J. Gynaecological morbidity among HIV positive pregnant women in Cameroon. Reprod Health 2008, 5:3.
9. Didelot-Rousseau M.N., Nagot N., Costes-Martineau V., Vallès X., Ouedraogo A., Konate I., et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer 2006, 95(3):355-362.
10. Yamada R., Sasagawa T., Kirumbi L.W., Kingoro A., Karanja D.K., Kiptoo M., et al. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol 2008, 80(5):847-855.
11. Moodley M., Garib R. The significance of human papillomavirus infection detected by cervical cytology among women infected with the human immunodeficiency virus. J Obstet Gynaecol 2004, 24(8):903-906.
12. Gaym A., Mashego M., Kharsany A.B., Walldorf J., Frohlich J., Karim Q.A. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations. S Afr Med J 2007, 97(2):120-123.
13. Chirenje Z.M., Loeb L., Mwale M., Nyamapfeni P., Kamba M., Padian N. Association of cervical SIL and HIV-1 infection among Zimbabwean women in an HIV/STI prevention study. Int J STD AIDS 2002, 13(11):765-768.
14. Leroy V., Ladner J., De Clercq A., Meheus A., Nyiraziraje M., Karita E., et al. Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE). Sex Transm Infect 1999, 75(2):103-106.
15. Motti P.G., Dallabetta G.A., Daniel R.W., Canner J.K., Chiphangwi J.D., Liomba G.N., et al. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi. J Infect Dis 1996, 173(3):714-717.
16. La Ruche G., Ramon R., Mensah-Ado I., Bergeron C., iomandé M., Sylla-Koko F., et al. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group. Cancer 1998, 82(12):2401-2408.
17. Parham G.P., Sahasrabuddhe V.V., Mwanahamuntu M.H., Shepherd B.E., Hicks M.L., Stringer E.M., et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006, 103(3):1017-1022.
18. Kapiga S.H., Msamanga G.I., Spiegelman D., Mwakyoma H., Fawzi W.W., Hunter D.J. Risk factors for cervical squamous intraepithelial lesions among HIV-1 seropositive women in Dar es Salaam, Tanzania. Int J Gynaecol Obstet 1999, 67(2):87-94.
19. Mosoko J.J., Macauley I.B., Zoungkanyi A.C., Bella A., Koulla-Shiro S. Human immunodeficiency virus infection and associated factors among specific population subgroups in Cameroon. AIDS Behav 2009, 13(2):277-287.
20. Heard I., Palefsky J.M., Kazatchkine M.D. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004, 9(1):13-22.
21. Guzder R.N., Gatling W., Mullee M.A., Mehta R.L., Byrne C.D. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. Diabet Med 2005, 22(5):554-562.